---
schema_version: "secwatch.filing_event.v1"
accession: "0001809519-24-000029"
form_type: "8-K"
ticker: "GDRX"
cik: "0001809519"
company_name: "GoodRx Holdings, Inc."
filed_at: "2024-02-29T23:59:59+00:00"
generated_at: "2026-06-05T07:13:44.656291+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# GoodRx Q4 revenue $196.6M; net loss $25.9M; adj. EBITDA $57.3M

## Summary
- Q4 2023 revenue $196.6M, net loss $25.9M (13.2% margin), adjusted net income $31.1M (15.8% margin).
- Full year 2023 revenue $750.3M, net loss $8.9M, adjusted EBITDA $217.4M (28.6% margin).
- Q4 net cash from operations $15.9M; exited with over 7M consumers of prescription offerings.
- Interim CEO Scott Wagner expects continued topline growth in Q1 and full year 2024.

## SEC filing metadata
- accession: 0001809519-24-000029
- form_type: 8-K
- ticker: GDRX
- cik: 0001809519
- company_name: GoodRx Holdings, Inc.
- filed_at: 2024-02-29T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1809519/000180951924000029/0001809519-24-000029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1809519/000180951924000029/gdrx-20240229.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001809519-24-000029
- JSON: https://secwatch.observer/filing/0001809519-24-000029.json
- Plain text: https://secwatch.observer/filing/0001809519-24-000029.txt

## Key facts
- Earnings Releases
  GoodRx Holdings, Inc. reported financial results for the three months and year ended December 31, 2023.
  - Period: the three months and year ended December 31, 2023
  - Result: reported results
  source text: On February 29, 2024, GoodRx Holdings, Inc. (the “Company”) announced the Company’s financial results for the three months and year ended December 31, 2023. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this report.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000180951924000029/0001809519-24-000029-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.